Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
<< anterior 21 a 40 de 160 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Garattini S, Bertele V. Europe's opportunity to open up drug regulation. BMJ 2010;340:842-3. [Ref.ID 88339]
23. Cita con resumen
Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M. Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 2009;361:1466-74. [Ref.ID 86863]
24. Cita con resumen
Anónimo. Myths and morality at Coca-Cola. Lancet 2009;373:1224. [Ref.ID 85609]
25. Cita con resumen
Anónimo. Transparency rules at the Cleveland Clinic. Lancet 2008;372:2002. [Ref.ID 84758]
26. Cita con resumen
Spillane C. 2008 stock tracker: how robust is pharma?. Scrip 100 2008:25-7. [Ref.ID 84686]
27. Cita con resumen
Mills J. French association links with Bordeaux university. Scrip 2008;3419/20:32. [Ref.ID 84669]
28. Cita con resumen
Roberts I. Corporate capture and Coca-Cola. Lancet 2008;372:1934-5. [Ref.ID 84660]
29. Cita con resumen
Mills J. UK law lords refuse NICE appeal in Eisai case. Scrip 2008;3411/3412:1,4. [Ref.ID 84465]
30. Cita con resumen
Charlish P. The biotech company league table. Scrip Executive Briefing 2008;1:1-12. [Ref.ID 84386]
31. Cita con resumen
Tanne JH. US senators propose body similar to NICE to assess treatments. BMJ 2008;337:372. [Ref.ID 83762]
32. Cita con resumen
Steinbrook R. Disclosure of industry payments to physicians. N Engl J Med 2008;359:559-61. [Ref.ID 83691]
34. Cita con resumen
Anónimo. Genentech meets expectations but Avastin concerns dampen outlook. Scrip 2008;3329:9. [Ref.ID 82031]
35. Cita con resumen
Kmietowicz Z. MPs' report criticises influence of drugs industry. BMJ 2008;336:111. [Ref.ID 82015]
36.Tiene citas relacionadas Cita con resumen
Adshead F, Stachenko S. International cooperation to combat chronic diseases. Lancet 2007;370:2078-80. [Ref.ID 81845]
37. Cita con resumen
Tanne JH. FDA may allow drug companies to promote "off-label" uses. BMJ 2007;335:1229. [Ref.ID 81788]
38. Cita con resumen
Tanne JH. US companies are fined for payments to surgeons. BMJ 2007;335:1065. [Ref.ID 81633]
39. Cita con resumen
Anónimo. Genentech exec responds to angry US ophthalmologists. Scrip 2007;3315:11. [Ref.ID 81621]
40. Cita con resumen
Campbell EG. Doctors and drug companies - Scrutinizing influential relationships. N Engl J Med 2007;357:1796-7. [Ref.ID 81398]
Seleccionar todas
 
<< anterior 21 a 40 de 160 siguiente >>